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Abstract. Age-specific population immunity to many vaccine-preventable diseases can be measured using sero-
logical surveys. However, stand-alone serological surveys are infrequently conducted in low- and middle-income
countries because of costs, operational challenges, and potential high refusal rates for blood collection. Nesting a
serosurvey within a household cluster survey may overcome some of these challenges. We share lessons learned from
nesting a serosurveywithin ameasles and rubella vaccinationpost-campaign coverage evaluation survey (PCES). In 15of
the 26 PCES clusters in Southern Province, Zambia, we collected dried blood spots from 581 participants aged 9months
and older. Household participation rates for themain PCESwere higher in the serosurvey clusters (86%) than PCES-only
clusters (71%), suggesting that a serosurvey can be successfully integrated without adversely affecting PCES partici-
pation. Among households that participated in the PCES, 80%also participated in the serosurvey and 86%of individuals
available in the household provided a blood sample for the serosurvey. Substantial planning and coordination, additional
staff training, and community mobilization were critical to the success of the serosurvey. Most challenges stemmed from
using different data collecting tools and teams for the serosurvey and PCES. A more efficient design would be to fully
integrate the serosurvey by adding blood collection and additional questions to the PCES.
Age-specific population immunity, measured as the pro-
portion of individuals across age strata with protective levels of
antigen-specific immunoglobulin G antibodies, can be esti-
mated using serological surveys for many vaccine-preventable
diseases (VPDs).1 However, serosurveys are infrequently con-
ducted in low- and middle-income countries because of cost,
operational challenges to blood collection, transport and pro-
cessingof samples, andconcernsaboutparticipant refusal rates
for blood collection.2–5 Instead, specific population immunity is
commonly inferred from vaccination coverage estimates, which
may be inaccurate and do not reflect true population immunity
because of primary and secondary vaccine failure and exposure
tonatural infection.2,5,6Rigorouslydesignedserosurveysdirectly
measure population susceptibility and immunity and can be
used to assess the proportion of children protected after a vac-
cination campaign.1 Knowledge of age-specific immunity pro-
files, spatial clustering, andsusceptibility amongsubpopulations
can guide targeted vaccination activities and improve the effi-
ciency of immunization programs.7,8
For serological surveillance of VPDs to be practical and
sustainable, serosurveys should ideally be conducted within
existing surveillance systems or multipurpose household
surveys, such asDemographic andHealth Surveys orMultiple
Indicator Cluster Surveys, nationally representative surveys
for malaria or human immunodeficiency virus infection, or
post-campaign coverage evaluation surveys (PCES).9 We
nested a serological survey within a PCES in one province of
southern Zambia following a national measles and rubella
(MR) vaccination campaign. We describe the processes that
enabled successful implementation of the nested serosurvey
and highlight the challenges and lessons learned.
The national catch-up MR vaccination campaign was con-
ducted in Zambia from September 19 to 24, 2016. The cam-
paign targeted children aged 9months to 15 years, and it was
the first time a rubella-containing vaccine was administered
nationally in Zambia. Two months after the MR campaign,
the Ministry of Health (MoH) commissioned a PCES, a na-
tionwide household cluster survey aimed at measuring
vaccination coverage achieved by the campaign and routine
vaccination.10 Data collection for the PCES was conducted
between November 21 and December 3, 2016. The PCES
used a two-stage cluster survey design adapted from the
WHOVaccination Coverage Cluster SurveyManual to select
30 clusters per province with probability of cluster selection
proportional to estimated size and 12 households per
cluster.11
To measure age-specific population immunity to MR viru-
ses, the serosurvey team partnered with the PCES team to
conduct a serological survey using dried blood spots (DBS) in
Southern Province, Zambia. Although the PCES was con-
ducted throughout the country, the nested serosurvey was
conductedonly in theSouthernProvince to leverageaccess to
a laboratory with storage facilities and expertise in serology.
Measles and rubella were the primary antigens of interest for
both the PCES and serosurvey, but the target age ranges
differed. The PCES focused on children eligible for the vac-
cination campaign but the serosurvey aimed to evaluate
population immunity among children aged9months andolder
as well as adults, including rubella immunity amongwomen of
childbearing age. The sampling strategy for the serosurvey
was based on the design of the PCES and aimed to estimate
seroprevalence with a precision of ±5%. We assumed a 36%
nonparticipation rate for blood collection based on a previous
serosurvey.12,13
For logistical reasons, the serosurvey was conducted in a
random sample of 15 PCES clusters in the Southern Province.
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Overall, 249 of the 312 eligible households were enrolled in
the PCES survey in the Southern Province (Figure 1). The
serosurvey did not appear to impact household participa-
tion in the PCES as 71% of households in the PCES-only
clusters participated, compared with 86% of households
in the PCES plus serosurvey clusters. For the serosurvey,
124 (80%) PCES households were enrolled over 12 days. Of
those households that did not participate in the serosurvey,
8% were not available and 12% refused. Reasons for refusal
were different among households but were mostly because of
nonavailability of the head of the household at the time of the
serosurvey. One cluster, which represented 12 households,
refused to take part in both the PCES and the serosurvey
because the community was suspicious that personal in-
formation and blood would be used for satanic religious pur-
poses. Combining the PCES and serosurvey participation
rates, 69%of households eligible in the PCES sampling frame
were included in the serosurvey.
Within the 124 households that agreed to participate in the
serosurvey, 830 individuals were eligible and 675 (81%) of
them were available at the time of the serosurvey. Of the
available individuals, 581 (86%) participated and provided a
blood sample, 11% refused, 2% did not have caregiver
available to provide consent, and 1% were ineligible for other
reasons.
Planning and coordination were required at all levels and
throughout each stage of the survey. A technical coordination
group comprising MoH officials, WHO Zambia officials, and
PCES implementing partners worked with the serosurvey
planning team for 3 months before the PCES to develop
a coordination plan for the two surveys. The serosurvey
protocol was developed through a consultative process and
sought to minimize disruption to the PCES. For example,
two separate electronic questionnaires for the PCES and
serosurvey were used. To avoid repeating questions, data
from the PCES questionnaire were shared with the seros-
urvey team. Additional questions not captured by the PCES
were asked in the serosurvey questionnaire after the PCES
team completed their questionnaire.
In anticipation of hesitancy toward blood collection, the
serosurvey team developed a sensitization plan at the pro-
vincial, district, and community levels in collaboration with
MoHdistrictmanagement teams aimed at communicating the
purpose and procedures of the serosurvey to key stake-
holders in study communities. The plan was adapted from
previous household surveys that collected blood in the com-
munity and achieved good participation rates.12,14 A letter
from theMoHwas issued to the provincial and district medical
officers to inform staff about the serosurvey in their commu-
nities. Within each district, the district health management
FIGURE 1. CONSORT enrollment flow diagram comparing post-campaign coverage evaluation survey (PCES) plus serosurvey clusters and
PCES-only clusters in Southern Province, Zambia.
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teams implemented community sensitization based on
micro-plans developed for each study community. Typically,
the nurse in charge, the environmental health technician at
health facilities in the study communities, and a community
representative, such as a community health worker, con-
ducted door-to-door sensitization at least 3 days before the
survey and made announcements on the local radio station.
They facilitated meetings between the field team and the
local community leaders to introduce the serosurvey, and
community representatives accompanied the serosurvey
teams to all households during data collection, ensuring
continuity between the sensitization and serosurvey field
activities.
Each serosurvey field team comprised four data collectors
paired with two PCES data collectors. At least one of the four
serosurvey data collectors was a certified clinical staff trained
in collectingDBSandoneof the twoPCESdata collectorswas
the team leader. The serosurvey teamswere trained for 5 days
in eliciting immunization history, reviewing household-based
immunization records, informed consent process, fingerprick
blood collection, and DBS preparation. Collection of finger-
prick blood on DBS filter paper provided an advantage be-
cause it does not require staff with phlebotomy skills, cold
chain, or access to a centrifuge in the field, which are common
obstacles to blood collection in the field.15
Two separate ethical approvals were obtained for the
serosurvey and the PCES because serosurvey participants
were required to provide written informed consent. Ethical
approval for the serosurveywasobtained fromJohnsHopkins
Bloomberg School of Public Health Institutional Review
Board, Macha Research Trust Ethics Review Committee, and
the Zambia National Health Research Regulatory Authority.
Enrollment of all householdmembers, including those outside
the target age group for the PCES, increased the length of
interviews and moderately slowed data collection. On aver-
age, data collection took 2 days in a PCES-only cluster and
3 days in a paired PCES and serosurvey cluster.
Most challenges stemmed from the fact that two separate
electronic questionnaires were administered: one for the
PCES questions and the other for additional questions and
procedures relevant to the serosurvey (Figure 2). In addition,
the serosurveywas a research project and, therefore, required
additional ethical approvals, informed consent processes,
separate data collection tools, and linkage of household and
participant identification numbers during data analysis to
PCES data. A more efficient design would be to fully integrate
the serosurvey by adding blood collection and additional
questions to the PCES. This approach was not implemented
because of limited time in the planning phase, uncertainties
regarding the timeline and survey instruments, and the
concern expressed by the PCES leadership that adding
blood collection could increase refusals and induce a re-
sponse bias for the main survey. The participation rates for
the PCES were higher in the serosurvey clusters than those
for PCES-only clusters, and individual refusals for blood
collection were low although some hesitancy was observed.
Future surveys need to weigh the risks of refusal and its
potential impact on representativeness against the effi-
ciency, cost savings, and benefits of fully integrating blood
collection into PCES activities.
By successfully conducting a serological survey within the
PCES in Southern Province, Zambia, we demonstrated the
feasibility of nesting a serosurvey in a health-related house-
hold survey. With appropriate statistical and logistical adap-
tations, serological surveys can be implemented as part of
other planned household surveys, providing a platform for
blood collection to measure antibodies to vaccine-preventable
and emerging infectious disease antigens while leveraging
existing surveillance systems and resources. Lessons learned
from this study provide guidance for implementation of future
nested serosurveys (Figure 2).
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FIGURE 2. Lessons learned from nesting a serosurvey within a vaccination coverage survey. MoH = Ministry of Health.
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